-
April 04, 2013
Scripps Research Institute Appoints Immunology Researcher to Faculty
The Scripps Research Institute (TSRI) has appointed Laura Solt as assistant professor at the Florida campus.
-
April 03, 2013
Scripps Research Institute Scientists Identify First Potentially Effective Therapy for Human Prion Disease
Human diseases caused by misfolded proteins known as prions are some of most rare yet terrifying on the planet—incurable with disturbing symptoms that include dementia, personality shifts, hallucinations and coordination problems.
-
March 27, 2013
Scripps Florida Scientists Awarded Special Collaborative Grant to Develop Anti-Addiction Medication
As part of an unprecedented national effort to develop new drugs to treat neurological disorders, scientists from the Florida campus of The Scripps Research Institute have been awarded an innovative grant from the National Institute of Neurological Disorders and Stroke to help people break their addiction to nicotine.
-
March 25, 2013
Scripps Research Institute Scientists Uncover New Compounds that Dynamically Alter Cell Signaling and Expand Options for Developing Breast Cancer Treatments
Using a broad spectrum of analytical tools, scientists from the Florida campus of The Scripps Research Institute have uncovered a class of novel compounds that can alter cell signaling activity, resulting in a variety of responses including a strong anti-inflammatory effect. These findings could lead to new strategies for treating diseases such as breast cancer.
-
March 21, 2013
Scripps Research Institute Study Underlines Potential of New Technology to Diagnose Disease
Researchers at The Scripps Research Institute (TSRI) in Jupiter, FL, have developed cutting-edge technology that can successfully screen human blood for disease markers.
-
March 14, 2013
Scripps Research Institute Appoints Innovative Biotech Scientist to Cancer Biology Department
The Scripps Research Institute (TSRI) has appointed Mark Sundrud as an assistant professor in the Department of Cancer Biology.
-
March 13, 2013
Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
The Scripps Research Institute (TSRI) and the Takeda Pharmaceutical Company have announced plans to expand their recent research collaboration to search for new drug targets for a variety of diseases.
-
February 21, 2013
Scripps Florida Scientists Awarded $2 Million to Study Tumor-Inhibiting Proteins
Scientists from the Florida campus of The Scripps Research Institute have been awarded just over $2 million from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health to identify proteins that play key roles in tumor cell proliferation and to determine if targeting these proteins could result in the inhibition of tumor growth.
-
February 20, 2013
Scripps Florida Scientist Awarded Prestigious Javits Neuroscience Investigator Award
Ron Davis, PhD, chair of the Neuroscience Department on the Florida campus of The Scripps Research Institute, has been selected to receive a prestigious $3.5 million Jacob K. Javits Neuroscience Investigator Award for his work on the complex biology of memory formation and the disorders that disrupt it.
-
February 07, 2013
Compound Developed by Scripps Florida Scientists Protects Heart Cells During and After Attack
Using two different compounds they developed, scientists from the Florida campus of The Scripps Research Institute (TSRI) have been able to show in animal models that inhibiting a specific enzyme protects heart cells and surrounding tissue against serious damage from heart attacks.
-
January 30, 2013
Scripps Research Institute Scientists Uncover a Previously Unknown Mechanism of Memory Formation
It takes a lot to make a memory. New proteins have to be synthesized, neuron structures altered.
-
January 29, 2013
Scripps Research Institute Study Shows How Brain Cells Shape Temperature Preferences
While the wooly musk ox may like it cold, fruit flies definitely do not.
-
January 25, 2013
Scripps Florida Team Awarded $1.2 Million to Develop Drug Candidates for Rheumatoid Arthritis and Neurodegenerative Disorders
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded approximately $1.2 million from the National Institute of General Medical Sciences of the National Institutes of Health to identify, test and develop a series of drug candidates for a number of diseases, including rheumatoid arthritis, heart disease and several neurodegenerative disorders.
-
January 24, 2013
Scripps Research Institute Appoints Memory Researcher to Faculty
The Scripps Research Institute (TSRI) has appointed Assistant Professor Seth Tomchik as a laboratory head on the Florida campus.
-
January 23, 2013
Scripps Research Institute Names David Blinder to Key Fundraising Position
The Scripps Research Institute has appointed David Blinder, PhD, as senior vice president for external affairs at The Scripps Research Institute (TSRI).
-
January 10, 2013
Scripps Florida Scientists Uncover Potential Drug Target to Block Cell Death in Parkinson's Disease
Oxidative stress is a primary villain in a host of diseases that range from cancer and heart failure to Alzheimer’s disease, Amyotrophic Lateral Sclerosis and Parkinson’s disease. Now, scientists from the Florida campus of The Scripps Research Institute have found that blocking the interaction of a critical enzyme may counteract the destruction of neurons associated with these neurodegenerative diseases, suggesting a potential new target for drug development.
-
January 06, 2013
New Study Defines the Long-Sought Structure of a Protein Necessary for Cell-Cell Interaction
Scientists from the Florida campus of The Scripps Research Institute have solved part of the puzzle of how cells in all higher organisms bind to each other for the development, architecture, maintenance and function of tissues. The scientists have defined the structure of a protein essential to this process.